Calcul EQD2 Formula Calculator
Estimate equivalent dose in 2 Gy fractions (EQD2) using the linear-quadratic radiobiology model. Enter fractionation details, choose an alpha/beta ratio, and compare total dose, BED, and EQD2 instantly.
EQD2 Calculator
Enter your radiotherapy fractionation details and click Calculate EQD2.
What is the calcul EQD2 formula?
The calcul EQD2 formula refers to the computation of Equivalent Dose in 2 Gy fractions, commonly abbreviated as EQD2. In radiation oncology, clinicians frequently compare treatment schedules that use different doses per fraction. A standard external beam regimen may use 2 Gy per fraction, while a hypofractionated schedule may use larger fractions such as 2.66 Gy, 3 Gy, 5 Gy, or higher depending on disease site, treatment technique, and normal tissue constraints. Because these regimens are not biologically identical even when their total physical doses look similar, EQD2 gives a practical way to convert different schedules into a common language.
The formula is grounded in the linear-quadratic model, which estimates the effect of radiation on tissues by combining a linear component and a quadratic component of cell killing. The alpha/beta ratio is the critical tissue-specific parameter in this model. Tissues or tumors with a higher alpha/beta ratio are less sensitive to changes in fraction size, while those with a lower alpha/beta ratio are more sensitive to fractionation. That distinction is exactly why EQD2 matters: a 60 Gy course delivered in 30 fractions behaves differently than 60 Gy delivered in 20 fractions.
EQD2 formula and BED formula explained simply
To understand EQD2, it helps to start with BED, or Biologically Effective Dose. The BED formula is:
BED = D × (1 + d / (alpha/beta))
where:
- D = total dose in Gy
- d = dose per fraction in Gy
- alpha/beta = tissue-specific radiobiological parameter in Gy
Once BED is known, EQD2 translates that BED into the biologically equivalent dose if the treatment had been delivered using 2 Gy fractions. The resulting equation is:
EQD2 = D × ((d + alpha/beta) / (2 + alpha/beta))
This equation lets clinicians compare unlike regimens on a standardized basis. For example, if two schedules have the same EQD2 for a particular alpha/beta ratio, they are estimated to have similar biological effect in that tissue under the assumptions of the model. In routine practice, alpha/beta values around 10 Gy are often used for many tumors or early-responding tissues, while 3 Gy is often used for late-responding normal tissues. For prostate cancer discussions, lower values such as 1.5 Gy are commonly explored in the literature.
Why dose per fraction changes everything
Suppose a patient receives 60 Gy in 30 fractions. The dose per fraction is 2 Gy, so the EQD2 is simply 60 Gy regardless of alpha/beta, because the schedule already uses 2 Gy fractions. But if the same total dose of 60 Gy is delivered in 20 fractions, the dose per fraction becomes 3 Gy. In that case, the biological effect rises for many tissues, especially those with low alpha/beta values. This is why simply quoting the total dose can be misleading. Fraction size must be considered.
How to calculate EQD2 step by step
- Determine the total dose delivered, D.
- Determine the dose per fraction, d.
- Select an appropriate alpha/beta ratio for the tissue or tumor of interest.
- Apply the BED formula: BED = D × (1 + d / (alpha/beta)).
- Convert BED to EQD2 using the 2 Gy reference fraction size.
- Interpret the result within the proper clinical context.
Worked example
Imagine a schedule of 40 Gy in 15 fractions. The dose per fraction is 2.67 Gy. If we use alpha/beta = 10 Gy for tumor effect:
- D = 40 Gy
- d = 2.67 Gy
- EQD2 = 40 × ((2.67 + 10) / (2 + 10))
- EQD2 = 40 × (12.67 / 12)
- EQD2 ≈ 42.2 Gy
Now repeat the same schedule for alpha/beta = 3 Gy as a late-effects lens:
- EQD2 = 40 × ((2.67 + 3) / (2 + 3))
- EQD2 = 40 × (5.67 / 5)
- EQD2 ≈ 45.4 Gy
The same physical schedule therefore maps to different biological equivalences depending on which tissue you are evaluating. This is one of the most important interpretive principles in radiobiology.
Comparison table: common fractionation schedules and estimated EQD2
| Schedule | Dose per fraction | EQD2 at alpha/beta = 10 Gy | EQD2 at alpha/beta = 3 Gy |
|---|---|---|---|
| 60 Gy in 30 fractions | 2.00 Gy | 60.0 Gy | 60.0 Gy |
| 55 Gy in 20 fractions | 2.75 Gy | 58.4 Gy | 63.3 Gy |
| 40 Gy in 15 fractions | 2.67 Gy | 42.2 Gy | 45.3 Gy |
| 30 Gy in 5 fractions | 6.00 Gy | 40.0 Gy | 54.0 Gy |
The table shows how larger fraction sizes may not increase tumor EQD2 dramatically when alpha/beta is high, but can increase the late-effect EQD2 much more when alpha/beta is low. This difference is one reason normal tissue tolerance remains central in hypofractionated and stereotactic approaches.
Real statistics that matter in clinical interpretation
When people search for calcul EQD2 formula, they often want more than a mathematical conversion. They want to know how the conversion fits into modern radiotherapy practice. Hypofractionation has become common in several disease sites, especially breast and prostate, because clinical trials have shown it can offer comparable tumor control with practical treatment benefits such as fewer visits and lower system burden. EQD2 helps clinicians interpret and compare these regimens.
| Clinical area | Representative schedule | Approximate fractions | Operational significance |
|---|---|---|---|
| Conventional whole-breast RT | 50 Gy in 25 fractions | 25 | Longstanding benchmark schedule |
| Moderate hypofractionated breast RT | 40 Gy in 15 fractions | 15 | 40% fewer fractions than 25-fraction treatment |
| Ultra-hypofractionated breast RT | 26 Gy in 5 fractions | 5 | 80% fewer fractions than 25-fraction treatment |
| Conventional prostate RT | 78 Gy in 39 fractions | 39 | Common historical high-dose convention |
| Moderate hypofractionated prostate RT | 60 Gy in 20 fractions | 20 | About 49% fewer fractions than 39-fraction treatment |
These are not statements that the regimens are universally interchangeable for every patient. Rather, they illustrate why biologically informed comparison tools are useful. Even when two schedules differ greatly in logistics, EQD2 gives a way to compare their expected biological intensity for specific tissues.
How alpha/beta ratio affects interpretation
The alpha/beta ratio is the pivot point of the entire calculation. A high alpha/beta ratio means the tissue response is driven more by total dose and is less influenced by fraction size. A low alpha/beta ratio means fraction size has a stronger effect. As a result:
- Higher alpha/beta tissues often show smaller EQD2 shifts when fraction size increases.
- Lower alpha/beta tissues often show larger EQD2 changes for the same increase in fraction size.
- Normal tissue protection becomes especially important as dose per fraction rises.
This is why the same 5-fraction regimen may seem modest from a tumor alpha/beta perspective yet much more intense from a late normal tissue perspective. In treatment planning, clinicians evaluate both sides of that balance, often alongside dose-volume histograms, image guidance considerations, target motion, and clinical trial evidence.
Common alpha/beta assumptions used in education
- 10 Gy: often used as a generic educational value for many tumors or early responding tissues.
- 3 Gy: often used for late responding normal tissues.
- 1.5 Gy: often discussed in prostate radiobiology literature.
These are simplifications. Real tissue response varies, and published estimates can differ across studies, endpoints, and modeling methods.
When the calcul EQD2 formula is most useful
EQD2 is particularly useful in the following scenarios:
- Comparing conventionally fractionated and hypofractionated schedules
- Evaluating dose escalation or de-escalation proposals
- Summarizing retreatment or composite dose discussions
- Teaching radiobiology to students, residents, and dosimetrists
- Interpreting literature where different schedules are reported across studies
Important limitations
No calculator should imply that radiotherapy can be reduced to one number. EQD2 has important limitations:
- The linear-quadratic model is an approximation.
- It does not independently account for overall treatment time, repopulation, repair kinetics, or heterogeneity in dose distribution unless those factors are added separately.
- Very large doses per fraction may stretch the assumptions of the classic model.
- The chosen alpha/beta ratio may not perfectly represent the tissue or endpoint being studied.
- Clinical outcomes depend on anatomy, motion management, image guidance, systemic therapy, surgery, and patient-specific factors.
How to use this calculator correctly
This calculator allows you to enter total dose, dose per fraction, and number of fractions. You can choose whether the final total dose should be driven by the entered total dose or instead derived from fractions multiplied by fraction size. That flexibility is helpful when you know a schedule in one form but want to check it in another. The calculator then computes total dose, BED, and EQD2 using the selected alpha/beta ratio and displays a visual chart for quick comparison.
Best practice tips
- Double-check unit consistency. Everything here is in Gy.
- Always specify the alpha/beta ratio when quoting EQD2.
- If discussing toxicity, consider evaluating more than one alpha/beta assumption.
- Use published protocols or peer-reviewed literature to anchor interpretation.
Authoritative sources for further study
For readers who want more depth, these authoritative sources are helpful starting points:
- National Cancer Institute (.gov) Radiation Therapy Overview
- NCBI Bookshelf (.gov) Radiation Therapy Principles
- University of Utah (.edu) Radiation Biology Educational Resource
Final perspective on the calcul EQD2 formula
The calcul EQD2 formula is one of the most useful bridges between raw dose numbers and biological interpretation in radiation oncology. It helps convert different fractionation schedules into a shared reference framework based on 2 Gy fractions, making it easier to compare plans, discuss tradeoffs, and understand the significance of dose per fraction. Its value is greatest when used thoughtfully, with an explicit alpha/beta assumption and with full awareness of its limits. If you are using EQD2 in a professional setting, always pair it with disease-site evidence, organ-at-risk constraints, and expert clinical review.